Grupo para la caracterización molecular de las neoplasias hematológicas
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas Southwestern Medical Center (1)
2024
-
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
The Lancet Oncology, Vol. 25, Núm. 8, pp. e374-e387